Union Savings Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Hold
1,200
0.09% 119
2026
Q1
$203K Hold
1,200
0.09% 126
2025
Q4
$203K Buy
+1,200
New +$195K 0.09% 130
2025
Q2
$159K Hold
1,200
0.07% 137
2025
Q1
$153K Hold
1,200
0.08% 140
2024
Q4
$159K Hold
1,200
0.08% 135
2024
Q3
$175K Hold
1,200
0.09% 137
2024
Q2
$165K Hold
1,200
0.09% 138
2024
Q1
$165K Hold
1,200
0.09% 137
2023
Q4
$163K Hold
1,200
0.09% 137
2023
Q3
$147K Hold
1,200
0.09% 140
2023
Q2
$155K Buy
+1,200
New +$156K 0.09% 137

Other funds holding IBB

Union Savings Bank's IBB Position: Q2 2026 in Review

Union Savings Bank held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,200 shares worth $228K. The position accounts for 0.09% of the portfolio, ranked #119.

Union Savings Bank first reported a position in IBB in Q2 2023 and has held it in 12 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Union Savings Bank held 1,200 shares of iShares Biotechnology ETF worth $228K as of Q2 2026.
  • Union Savings Bank left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.09% of Union Savings Bank's portfolio in Q2 2026, its #119 holding.
  • Union Savings Bank first reported a position in iShares Biotechnology ETF in Q2 2023 and has held it in 12 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Union Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.